Excipients & Specialty Ingredients
Company Overview
About
Future Fields is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:Canada
Founded:2007
Employees:1,840
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval P0EX03
EMA · #APR-7464EJX2 · 2022-04-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-XLO4PS0M
Issued: 2020-07-10
Expires: 2025-06-24
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-J1UI2LXX
Issued: 2020-12-26
Expires: 2025-01-13
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-WM6X3Q40
Issued: 2020-11-16
Expires: 2025-10-25
Health Canada GMP
Health Canada
Cert #: CERT-ZURZK4H0
Issued: 2020-09-25
Expires: 2025-06-10
Loading CDMO intelligence...
Key facts about Future Fields
- Future Fields is headquartered in Canada.
- Future Fields was founded in 2007.
- Future Fields has 1,840 employees.
- Future Fields's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Future Fields
Directory pages this company appears in, each with the full list of matching manufacturers.